Leidos Holdings, Inc. (LDOS) Earnings Call Transcript & Summary

August 9, 2022

New York Stock Exchange US Industrials Professional Services conference_presentation 28 min

Earnings Call Speaker Segments

Sheila Kahyaoglu

analyst
#1

Good afternoon, everyone. My name is Sheila Kahyaoglu, with the Jefferies Aerospace and Defense Equity Research team. And thank you to Stuart and Roger for being here today. We have Roger Krone, who's CEO and Chairman of Leidos. Roger is the man that does it all.

Sheila Kahyaoglu

analyst
#2

So with that, Roger, I wanted to ask you about how you differentiate Leidos relative to peers? We were just talking about your upcoming Analyst Day in Huntsville. I think that's one unique aspect, but if you could talk about it a little bit.

Roger Krone

executive
#3

Yes, great. Well, first of all, Sheila, thanks for having us here, and thanks for holding the conference. And it's really great to be back in person and meet people again. I actually ran into folks I haven't met -- I have been physically with in 2 or 3 years. And some, maybe even longer. Alan and I have spent a lot of time together in the marketplace; Alan from OSI, who is here before us. We're really excited about what we do at Leidos and our business model because as we have evolved as a company and invested more in research and development and developing our own intellectual property, we own more, we do more, we build more. And so the substance that we bring to problems, we think, is differentiated and deeper and more competitive than some of the people that were usually compared to. Some of our competitors are really only providers of people. And we've always liked to say we're not in the IT services business, we're in the solutions business. We want to do more than just provide the people who get the work done. We want to actually invent a solution, synthesize the solution and bring the solution to the customer. And so for us, that's always meant investing in R&D, doing prototyping, modeling a simulation, being able to talk to the customer what their problems are, and then bringing all aspects of the solution, which could be software, it could be hardware, it could be firmware, it could be processes. Often, we actually go out and we buy a platform like we do in our airborne ISR business. And we modify the platform, and then we actually provide the pilots and the analysts who are in the platform. So we're -- it's a great model for us because it gets us into a lot of broader markets than some of our competitors. And clearly, it's worked well and it's fueled the growth that we've had, at least in the tenure that I've been with the company.

Sheila Kahyaoglu

analyst
#4

And maybe if you could talk about your 2022 guidance? With organic growth, I think, being pretty good in the first half, up 4%, implying 1% growth in the second half. What are some of the headwinds in the second half that you're calling out or maybe just creating a space for?

Roger Krone

executive
#5

Yes. And I know there was a lot of discussion at the earnings call because we just reaffirmed our guidance, right? So -- and then we had some prepared comments that we felt we were sort of in the upper half of the top line, but maybe not in the upper half of the bottom line. And so I think that speaks to -- we continue to see strong demand for what we do. We've got programs that are ramping. Our Defense Enclave Services, which I'm sure we'll come back, to the AEGIS program, our military family life and counseling program, and then this program we call Reserve Health Readiness, all of which are growing and adding to the top line. But at the same time, we've seen some headwinds, right? We've seen outlays down when we expected the money to actually flow through the government process faster. We expected some awards to happen earlier. So even our AEGIS program, we had hoped to be under contract earlier and to be further along in the ramp than we are. And then a really important part of our business is what we call on-contract growth, which really comprises a variety of additional revenue we can generate on a contract where we're either doing additional project work under a task order or there's a new task orders. And just because of the slowness of the procurement system on programs like our Navy NextGen, we just have not seen the special project work come through the acquisition system. And so that just caused us to merely reaffirm the guidance that we had out there rather than grow it. I know you're going to ask about longer term, we're still bullish on the longer term. We've seen some really good numbers coming out of the administration. And we're excited about '23 and '24. We just didn't see ourselves in a position where we wanted to touch guidance, and I'll come back to 2 health programs. The DHMSM program, which we have signaled for a long time, has sort of reached its high watermark from a deployment standpoint. We deploy the electronic health care records in waves. We've probably seen our max revenue quarter still have actually many years of strong performance, but we are probably past 50% on the program. And then a real swinger for us, and Sheila, you may want to come back and talk more about it, is our medical exam business and what's really going on there. And as we look at the second half, we made the assumption that we have worked off our COVID backlog, and that it's too difficult for us to predict what we call the result of the presumptive cases or the PACT Act. And again, if you want to talk more about that we can.

Sheila Kahyaoglu

analyst
#6

I'm going to ask you since you want me to talk about it. What is going on in your medical exam business? And I think that act was approved Wednesday night, your call was on Tuesday, so you didn't get to fully let us know.

Roger Krone

executive
#7

Yes. Well, what happened -- so there are a series of medical conditions that the VA has gone back to the administration and said that they want to include as a benefit. In order to make that happen, there needs to be a legislation passed. And so the Senate passed the PACT Act, and the P is for presumptive. And so there were burn pits in the Mid-East AOR that had toxic chemicals. There's asbestos on ships. There's a readjudication of agent orange. But it opens up literally hundreds of thousands of new cases for veterans. And a point I'd like to make about our exam business. Unlike most of what I talk about, our exam revenue is a mandatory payment, right? So once the law is passed, then we, as taxpayers, we owe a benefit to the veteran. And it's kind of like interest on the debt, and it ends up not in the discretionary accounts, but in the mandatory accounts. And so hopefully, today when the President signs the PACT Act, that will open the opportunity for the VA, to readjudicate and -- for the burn pits, first time adjudicate hundreds of thousands of new medical cases which will require exams. And then based upon what we find in the exam and the degree that is disabled, there'll be payments. So as we were coming off of what I call the COVID backlog where we had to shut down our clinics and we really had expected the second half to be significantly lower and therefore, lower in margin because it's sort of a fixed cost type business, there is the potential to start to see some strengthening of our top line on the exam business. That being said, we had hoped that the PACT Act would have been signed a month ago and then we thought it was going to be 2 weeks ago, and then it was last week, and it still -- it's been passed, but it hasn't been signed by the President. So once it's signed and the VA, we'll start to find their claimants. They will send us cases that we have to contact the veteran. We have to schedule an appointment, we have to conduct the exam, and then we have to prepare that exam, submit it to the VA, it's got to be accepted, and then we can recognize revenue. And then eventually, like 2 weeks or 4 weeks later, we'll get paid. So you can see from that line of things that have to happen, we've already lost 1 month, 1.5 months of the quarter. I don't expect to see much revenue from the presumptives in the third quarter. We're hopeful we'll see some lift in the fourth quarter. So it could help in the second half to help with our top line. When we put our guide out, we were very conservative about the impact of the PACT Act in our exam business. But it will be a strong number for '23 that we've talked on the call, and you know well, we got to recompete in what we call our District 6 claims where we were the sole provider, and now there are 3 providers, but we added to that the international business. And we see that not quite a net, net, but certainly some downward pressure on margin. But overall, it's a great business. Taking care of vets is a terrific responsibility. We love what we do. We love giving the veterans a terrific experience and help them get the reimbursements that they deserve.

Sheila Kahyaoglu

analyst
#8

So yes, I think it was on the President's desk back in June 21. So it's expected to be signed imminently, is the thought process.

Roger Krone

executive
#9

I was hoping before I came up to speak.

Sheila Kahyaoglu

analyst
#10

Okay. Well -- and we'll keep googling it. In terms of just scope of how large the VA contract is and how additive the PACT Act could be?

Roger Krone

executive
#11

Well, we don't -- obviously, we don't give out any specific numbers. We look at that part of the business, and we've now lumped RHRP and with QTC. And it's -- when you take all of the work that we have and RHRP, it is on the order of $1 billion business. So it's a significant part of what we do, without going how that all gets broken down. And I'm just going to tell you, we don't know how big the PACT Act can be. I mean, we have a sense. It is literally hundreds of thousands of claims, maybe 250,000 claimants. How fast that happens, how quickly we can do exams, it could be 5%, it could be in order of that magnitude, but we just won't know. We'll have a lot more to say about it on the next earnings call. But it's all, frankly, upside, and we expect probably to get a full year of presumptive claims in '23. So we'll have more to say next quarter.

Sheila Kahyaoglu

analyst
#12

Not a bad problem to have.

Roger Krone

executive
#13

Not a bad problem to have. Well, it's okay for us as a business. It's sort of a horrible thing for the veteran. And the burn pits -- just it is what it is, and a lot of people inhaled a lot of bad stuff. And now we need to do the exams and get them the benefit they deserve.

Sheila Kahyaoglu

analyst
#14

At least you're providing a benefit.

Roger Krone

executive
#15

Yes.

Sheila Kahyaoglu

analyst
#16

And moving on to DES contract. You cleared the protest. In the last time we spoke, you were holding your breath. So I was very happy for that. You've been very clear the incremental revenues this year are minimal and it's not really additive on the bottom line. How do we see that contract ramping over the next few years?

Roger Krone

executive
#17

Yes. Sheila, really interesting. So on one hand, we celebrate what is probably the largest contract we've ever won at Leidos with a ceiling value of $11.5 billion, and we booked almost nothing into backlog. So on the charts that I get to see, there's a big upward spike, and the charts that you get to see, there's almost nothing. So we've talked about this year being double digits. And next year, we might double that, but we're not going to reach $100 million next year. And the way the program works, for those who are not familiar with it, we partner with DISA to establish something called the DoD 1 Net, which is a modern open IT architecture, and then we install that architecture. We start, frankly, with DISA headquarters as sort of our beta, and then we go to other, they call them Fourth Estate non-combat organizations within the Department of Defense. And we start with headquarters, and we do a couple of small agencies. And with every installation, we kind of make our own future. And so this year, we're doing a lot of design work. And we're fully under contract, and we're working with the customer. In fact, I met with General Skinner, who's the head of DISA about 2 weeks ago, and we talked about the program. So we will start just DISA headquarters towards the end of the year or next year. We'll probably add a couple of installs next year. And then it probably doubles again in '24, and it probably doubles again in '25. And then the ability for us to get anywhere near $11.5 billion divided by 10, it's a 10-year contract, we have to be successful every day. We have to prove to the owners of these networks, the Defense Logistics Agency, the Defense Health Agency, that we can provide them their network, frankly, faster, better and, frankly, more cyber secure. And so we make our future every time we do an install. By the way, very much like we do in the defense health program with electronic health care records. The next wave in DHMSM is kind of always dependent on how successful we were in the last wave. And we've done a great job on DHMSM. There's no reason why in 4 years, 5 years, this can't be a program literally north -- in the north end of hundreds of millions of dollars a year.

Sheila Kahyaoglu

analyst
#18

And then you've done a few acquisitions over the past few years that I think have changed Leidos' capability, whether it was Dynetics, Gibbs & Cox stands out as adding ship design capability. Can you maybe talk about the broader growth opportunities. Maybe we'll stick to Gibbs & Cox and what you're seeing on the naval side?

Roger Krone

executive
#19

Sure. I'd love to talk about that. Our M&A history is pretty unique. We had the terrific opportunity to do the IS&GS deal through a reverse Morris trust, which didn't leave us to double negative. We didn't have to overly leverage to get the Lockheed deal done. So we came out of the Lockheed deal with great firepower. And then we've kind of looked at our long-term strategy and where we wanted to grow. And I don't like the word bolt-on. I don't think anyone ever wants to feel, they've been bolted on. But we look for either technology or market plays in smaller M&A. And that's what we've been doing. Dynetics is like that 1901, the L3 business in the security and inspection. And with both Dynetics and Gibbs & Cox, not only do we get great people and great technology and market presence and leadership, we got their DNA, right? Their entrepreneurial, entrepreneurial view, the customer relations, how they go to market, how they view growth in their business. And the way we have organized, both of those businesses, we have combined with existing Leidos businesses. So in maritime, we had an existing maritime business that built something called, Sea Hunter which is our autonomous platform and that we essentially have put Gibbs & Cox our maritime businesses together to cross-fertilize the discipline and program management technology we had on the maritime side with these people who love ships and ship design and love the Navy and just talk about ships all the time. And we did the same thing with Dynetics and the Leidos Innovation Center, which is where space business is and things that we've done in wide field of view. Gibbs & Cox, again, we have been so fortunate to do some very unique acquisitions. And I think it's because of the culture. Gibbs & Cox was the last remaining independent naval architecture firm in the United States. All the other ship design work in the U.S. was done by one of the existing yards. And probably not known to many people, 60% of the U.S. Navy's current surface combatants were designed by Gibbs & Cox. So we did the Arleigh Burke. We did the Freedom-class LCS. We did the old Frigate. We have a contract for the new Frigate, and we have a contract for the new Destroyer. So that book of business is really exciting, but even more exciting for us, we learned bidding in the medium-sized undersea vehicle, the unmanned vehicle -- surface vehicle. We knew a lot about autonomy, and we knew a lot about ship design, but we didn't know a lot about U.S. Navy ship design. And so what Gibbs & Cox brings to us as we combine our technology with their knowledge of how the Navy wants a ship designed and operated and should help us expand our business in the unmanned surface vehicle market, both in the U.S. and overseas. And then neither of us have done a lot in the undersea and we just won a very small contract called medium undersea autonomous vehicle and have gone to market on that. It's small. You probably won't see it in any of our press releases. But combining what we learned from Gibbs & Cox with the autonomy work that we did at Leidos helps us to address a market that we couldn't address without the acquisition.

Sheila Kahyaoglu

analyst
#20

And what's going on with Dynetics? How big was the business when you acquired it back in 2020? And what does it look like today? And just given the growth profile of some programs such as Epic?

Roger Krone

executive
#21

Yes. I'll try to remember, so don't hold me to the exact numbers. I think it was about kind of nominally $800 million when we bought it, and it's about twice that now. I mean, give or take, $50 million. And it grew by winning programs, in doing virus program, the hypersonic glide body program is growing, some of the weapons programs are growing. And then we combined it with our Leidos Innovation Center, which was not as big as Dynetics, it's probably in the $400 million or $500 million business. And then we had, if you will, new organic growth on top of that. And it's been a fantastic combination. I mean it's -- if you talk to Steve Cook, who runs that business and we're doing an investor opportunity in December for those people who want to come visit. But to see them come together -- and again, it's the entrepreneurial people at Dynetics and the technology that we essentially had trapped in the Leidos Innovation Center. And what Dynetics knows how to do is to apply technology to create a program, and then transition a research program to a program of record. And what we had done really well in the Leidos Innovation Center was demonstrate technology like the Sea Hunter program, the CHIRP program, our IR payload program. But what we had failed to do is to bridge what we all refer to as the valley of death into production programs. And we're now on the verge of moving 4 or 5 of those collective programs across the valley into production. So these enduring fires program, both the high-energy laser, in fact, the Lockheed laser is literally at our facility being installed on the chassis as we're here. We will probably be shooting light in the next couple of weeks. I'd say you can probably see that when you come down in December, but it may be out in test, but there's a second platform right behind it. The enduring [ FPIC ], which is the A9L, where we're a team with Raytheon, that's actually going well. That really doesn't need to bridge. All we have to do is connect it to the IBCS and shoot some missiles, and we've got a production program. So that looks really exciting. And then the common hypersonic glide body. We're under contract to get to a certain rate. We're now starting to see long lead to increase the rate there. It is, if you will, the nation's leading hypersonic capability in the worldwide battle to have a significant capability in hypersonics, and again, something that people can see if they're able to make the trip down in December. And I couldn't be more excited. And what it really gets to be going is how well the Dynetics and the link and some of the people from Reston who've kind of all come together in Huntsville to make it all work. And something we're not quite ready to completely talk about, but we are part of SDA's Tranche 0 program, which is a tracking layer. And then we bid with a company that won the Tranche 1 as the payload. And there's not much I can say at this point, but the company that we're teamed with won contract and has signed a contract with SD&A to go do their demo on the tracking layer and we're the payload provider. And again, that's the combination of Dynetics and the link actually putting a proposal together and teaming with a great prime to grow the business.

Sheila Kahyaoglu

analyst
#22

I have a minute left. So one more question, and I'm debating profitability or cap deployment. And since you just did the Cobham deal, you have -- ASR business is about $100 million. You added to it in the quarter, deals yet to close. How are you balancing cap deployment priorities from here given the $500 million ASR as well?

Roger Krone

executive
#23

Yes, that's great. Let's see. We're -- we guided about $1 billion in cash. If you add the lawsuit, it's probably $1.25 billion. Our cap deployment is about as consistent as it could be. And we actually look at the words that go into the script every quarter, and we say, we want to be a dividend player -- a payer. We don't necessarily want to be a regular dividend raiser. We're really listening to investors as what they want to do. And then after that, about half of what we have, we're going to invest in growth, and that could be R&D. It could be capital spend. We could buy some assets like airplanes. It could be M&A. And then the other half, we kind of want to give back to shareholders. And when we look at the year and where we were, where our stock price was and we said that it really looked opportune to do an ASR. The business in Australia is associated with Cobham, and Cobham was bought by PE and is being sold in pieces. We're very familiar with the airborne ISR business in Australia. They fly the same brand make aircraft that we fly around the world. So we have a, as you said, $100 million ISR business that flies Dash 8s and Challengers. And so we always thought we were the logical owner of the business, but we never though that we would actually be able to get to where we want to be on pricing terms. So we made a commitment to the ASR, early buyback. I think the market responded really well to the ASR. And then we just assumed that we would pay down the debt and finish the year. And then it just -- sometimes in M&A, you can't predict when opportunities present themselves. We view Australia as a terrific market because of great power competition, what's going on in South China Sea and things. Australia is going to be very strategically important to the world, to the U.S. as a partnership, the [ OCSE ] program. And so the ability to expand our presence in Australia in a different product line in something that we know well so integration risk is minimal. And Paul Chase, who runs our Australian operation, was a P3 Air Force person. And so he understands airborne ISR, so that was a doubling down. But we'll -- by the way, we have completely hedged the deal as of the date of signing, and we actually benefited from a little bit of the foreign currency move. We don't know when it will close. So Sheila, I mean if it closes quickly, then I suspect there would be no chance that we would be back in the market. If like some M&A, it gets significantly delayed, we're not going to accumulate cash. There's a potential that we could be back in the market earlier than we planned. But I guess the high percentage is it closed reasonably quick, end of third quarter, sometime in fourth quarter. And then as such, we want to delever. And we'll want to delever down to 3 before we're back in the market. And we've been pretty clear, we expect to be in the market on a regular basis as part of our capital deployment. And I got a question earlier today, a 1% excise tax probably doesn't change our mind. We are not hyperscaler. We're in for billions of dollars in buyback. Our ASR, 1% would have cost us, what, $5 million on the $500 million. And it's money we wish we didn't have to spend, but I would rather pay the 1% than see the corporate rate go up. So I guess it's your choice of evils, 1% excise on buybacks' probably better than what we could have seen, because at one time, we were thinking the corporate might go to 28. And so keeping the corporate rate where it is, it works for us. But we're committed to give back our great cash flow to our owners and our shareholders, and buyback has been and will be a significant part of that deployment strategy.

Sheila Kahyaoglu

analyst
#24

Great. Thank you so much, Roger, for being.

Roger Krone

executive
#25

Sheila, thanks. Thanks for your conference.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Leidos Holdings, Inc. transcript — plus 248,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Leidos Holdings, Inc. earnings transcripts and 248,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.